Global Health Ltd. (Medanta) Q2 FY26 Financial Performance & Strategic Capital Expenditure Update

Global Health Ltd. has released its consolidated financial results for the second quarter ending September 30, 2025, demonstrating robust top-line growth and significant strategic advancements. 📈 Q2 FY26 Financial Highlights Consolidated Net Profit: The company reported a 21.1% year-on-year (YoY) increase in consolidated net profit, which rose to ₹158.4 crore from ₹130.8 crore in the corresponding period last year. Revenue from Operations: Revenue grew by a steady 14.9% YoY, reaching ₹1,099 crore for the quarter. EBITDA Performance: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was recorded at ₹230.8 crore, reflecting a 1.1% increase YoY. EBITDA Margin: The EBITDA margin stood at 21.0% for the quarter, compared to 23.8% in Q2 FY25. This margin compression is reflective of higher operating costs incurred during the period. 🏥 Strategic Initiative: Mumbai Hospital Expansion In a significant move to strengthen its asset base and expand its footprint, the Board of Directors has approved a substantial expansion and revised capital allocation for its upcoming hospital in Mumbai. Enhanced Capacity: Following the receipt of additional Floor Space Index (FSI) approval from the Mumbai Housing and Area Development Authority (MHADA), the planned capacity for the Mumbai facility will be increased by 50%, from 500 beds to 750 beds. Revised Project Cost: To accommodate this expanded scope, the total project cost has been revised upward from ₹1,200 crore to ₹1,530 crore. Ancillary Investment: The board also sanctioned the strategic acquisition of 30 residential flats near the hospital site for ₹85 crore. This investment is intended to provide accommodation for key clinicians and essential staff, ensuring operational readiness and talent retention for the new facility.